Skip to main content

Keryx Biopharmaceuticals, Inc. (NASDAQ: KERX) Investor Lawsuit Filed Against Takeover

  • Investors who purchased shares of Keryx Biopharmaceuticals, Inc. (NASDAQ: KERX) and currently hold any of those NASDAQ: KERX shares have certain options and should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Lawsuit Overview

An investor, who currently holds shares of Keryx Biopharmaceuticals, Inc. (NASDAQ: KERX), filed a lawsuit against the takeover of Keryx Biopharmaceuticals, Inc. The plaintiff alleges that the defendants breached their fiduciary duties owed to NASDAQ: KERX stockholders by agreeing to sell Keryx Biopharmaceuticals, Inc. cheaply via an unfair process. On Jun. 28, 2018, Akebia Therapeut...



You must register (for free) or login to view the entire case.